| pubmed-article:15001676 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15001676 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
| pubmed-article:15001676 | lifeskim:mentions | umls-concept:C0006118 | lld:lifeskim |
| pubmed-article:15001676 | lifeskim:mentions | umls-concept:C0041485 | lld:lifeskim |
| pubmed-article:15001676 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:15001676 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:15001676 | lifeskim:mentions | umls-concept:C0040399 | lld:lifeskim |
| pubmed-article:15001676 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15001676 | pubmed:dateCreated | 2004-3-5 | lld:pubmed |
| pubmed-article:15001676 | pubmed:abstractText | The aim of this study was to compare PET with O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) and SPECT with 3-(123)I-iodo-alpha-methyl- L-tyrosine ((123)I-IMT) in patients with brain tumors. | lld:pubmed |
| pubmed-article:15001676 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15001676 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15001676 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15001676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15001676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15001676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15001676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15001676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15001676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15001676 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15001676 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15001676 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:15001676 | pubmed:author | pubmed-author:PauleitDirkD | lld:pubmed |
| pubmed-article:15001676 | pubmed:author | pubmed-author:CoenenHeinz... | lld:pubmed |
| pubmed-article:15001676 | pubmed:author | pubmed-author:TellmannLutzL | lld:pubmed |
| pubmed-article:15001676 | pubmed:author | pubmed-author:HautzelHubert... | lld:pubmed |
| pubmed-article:15001676 | pubmed:author | pubmed-author:LangenKarl-JK... | lld:pubmed |
| pubmed-article:15001676 | pubmed:author | pubmed-author:HamacherKurtK | lld:pubmed |
| pubmed-article:15001676 | pubmed:author | pubmed-author:FloethFrankF | lld:pubmed |
| pubmed-article:15001676 | pubmed:author | pubmed-author:MüllerHans-WH... | lld:pubmed |
| pubmed-article:15001676 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15001676 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:15001676 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15001676 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15001676 | pubmed:pagination | 374-81 | lld:pubmed |
| pubmed-article:15001676 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:meshHeading | pubmed-meshheading:15001676... | lld:pubmed |
| pubmed-article:15001676 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15001676 | pubmed:articleTitle | Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors. | lld:pubmed |
| pubmed-article:15001676 | pubmed:affiliation | Clinic for Nuclear Medicine, Research Center Jülich, Jülich, Germany. pauleit@web.de | lld:pubmed |
| pubmed-article:15001676 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15001676 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15001676 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15001676 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15001676 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15001676 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15001676 | lld:pubmed |
